IL-10 is a cytokine with multiple, pleiotropic, effects in

New Post Public Reply Private Reply Replies (2) Message Board
MGK_2 ohm20 #125906
603
Quote:
IL-10 is a cytokine with multiple, pleiotropic, effects in immunoregulation and inflammation. It downregulates the expression of Th1 cytokines, MHC class II antigens, and co-stimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. IL-10 can block NF-κB activity, and is involved in the regulation of the JAK-STAT signaling pathway.

Discovered in 1991,[19] IL-10 was initially reported to suppress cytokine secretion, antigen presentation and CD4+ T cell activation.[20][21][22][23] Further investigation has shown that IL-10 predominantly inhibits lipopolysaccharide (LPS) and bacterial product mediated induction of the pro-inflammatory cytokines TNFα,[24] IL-1β,[24] IL-12,[25] and IFNγ[26] secretion from Toll-Like Receptor (TLR) triggered myeloid lineage cells.

Effect on tumors
Over time a more nuanced picture of IL-10's function has emerged as treatment of tumor bearing mice has been shown to inhibit tumor metastasis.[27] Additional investigation by multiple laboratories has generated data that further supports IL-10's immunostimulatory capacity in an immunoncology context. Expression of IL-10 from transfected tumor cell lines[28][29] in IL-10 transgenic mice[30] or dosing with IL-10 leads to control of primary tumor growth and decreased metastatic burden.[31][32] More recently, PEGylated recombinant murine IL-10 (PEG-rMuIL-10) has been shown to induce IFNγ and CD8+ T cell dependent anti-tumor immunity.[33][34] More specifically, PEGylated recombinant human IL-10 (PEG-rHuIL-10) has been shown to enhance CD8+ T cell secretion of the cytotoxic molecules Granzyme B and Perforin and potentiate T cell receptor dependent IFNγ secretion.[35]


from here: https://en.wikipedia.org/wiki/Interleukin_10

If all Leronlimab did was reduce inflammation why would it REDUCE IL-10 when IL-10 was anti-inflammatory? IL-10 is a great anti-inflammatory and that is what you think LRM does.

No, LRM, stimulates the immune system to get the job done. We have had this conversation before. LRM allows the appropriate communication between the immune cells so that it can do the job it was meant to do, which is to restore health. When health is restored, there, you have your anti-inflammatory effect. When it is in the process of restoring health, you will see a properly executing immune system with elevations in inflammatory markers or cytokines, but that will soon result in an improved picture of health which will be reflected in a reduction in inflammation and associated markers.

As per the heat map, Interleukin 10 was only reduced in the 350mg group and HM groups. Why? 350 was effective in activating the metabolism of fibrosis and you don't want the suppressive effects of IL-10 when you are in that mode.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fresha Teams with Klarna: Shaking Up Beauty Payments

Updated Category News Views 54

New Flexibility at the Beauty Checkout Hey, if you've ever paced back and forth considering signing up for that luxury self-care spree, well, Fresha’s latest move might just tip the scales. The beauty and wellness booking giant has partnered with Klarna, diving headfirst into the Buy Now, Pay Later (BNPL) craze. It's about time, right? Everyone loves a good spa session,...

Continue Reading
Thunes, UnionPay Revamp China Payments with $10K Daily

Updated Category News Views 140

Unveiling a New Era for Cross-Border Payments Thunes is shaking things up, unleashing a fresh wave of possibilities for moving money into China's mainland. In a strategic twist, Thunes has teamed up with UnionPay International, aiming to transform the cross-border payment experience. With a potent combo of bank-grade security and hefty daily transaction limits, this...

Continue Reading
Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 176

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 148

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading
Clarivate Integrates Trademark Data with Microsoft AI

Updated Category News Views 0

You know, the market's all abuzz with AI this, AI that. But today, we're getting a glimpse at something that isn't just hyped-up vaporware; it's actually useful. Clarivate Plc (NYSE:CLVT), which has carved a niche in transformative intelligence, is teaming up with Microsoft to slide their CompuMark trademark data into Microsoft Copilot via something they call IPOne. It's...

Continue Reading
DriveNets' Big Role at FYUZ 26: AI Fabrics Spotlighted

Updated Category News Views 0

Networking Titans Gather at FYUZ 26 Alright, folks, mark the first week of November as a field day for telecom and AI networking enthusiasts. DriveNets, a seasoned player in large-scale networking, is joining forces with some of the industry's giants—AT&T, KDDI, and Broadcom—at the Telecom Infra Project's flagship event, FYUZ 26, unfolding at The Westin Seattle. From...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 63

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading
E-commerce Player Temu Protects GIs in New Partnership

Updated Category News Views 54

Temu Takes Action on Geographical Indications You ever get the feeling some companies actually give a damn about what they’re selling? Well, Temu's making moves that seem to argue just that. By stepping into the fold with oriGIn, the global network protecting Geographical Indications (GIs), Temu is staking its claim on protecting authenticity in the vast e-commerce...

Continue Reading
Potatoes vs. Candy: Halloween's Spuddy Surprise

Updated Category News Views 118

When Halloween rolls around, you expect rabid kids clamoring for candy corn and chocolate bars. But this year, Idaho threw a spud into the sweets machine. Idaho's Potatoes Steal the Show In an unexpected twist, the Idaho Potato Commission ran a zany experiment on Halloween: kids had to choose between their beloved Halloween candy and a genuine Idaho potato. Imagine the...

Continue Reading
ENGWE Unleashes Massive Black Friday E-Bike Discounts

Updated Category News Views 65

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Pickleball Warmer Designed for Enthusiasts

Updated Category News Views 118

Revolutionizing Pickleball Play in Cold Weather Inventors around the country are constantly looking for ways to improve athletic experiences. One recent innovation is the PICKLE BALL WARMER, a product that aims to enhance the game of pickleball. Pickleball players know how important it is to have equipment that works perfectly, especially when temperatures drop. With this...

Continue Reading
UnitedHealth Reports Earnings Surprise and Revenue Challenge

Updated Category News Views 216

UnitedHealth's Fourth Quarter Earnings Analysis Recently, UnitedHealth (NYSE: UNH) delivered its fourth-quarter earnings report, revealing an EPS of $6.81, surpassing the analyst expectation of $6.74 by $0.07. However, on the revenue front, the company reported $100.8 billion, slightly lower than the anticipated $101.61 billion. This mixed result has analysts abuzz...

Continue Reading
Insightful Earnings Preview for Ramaco Resources Unveiled

Updated Category News Views 213

Preparing for Earnings: Ramaco Resources' Insights Ramaco Resources (NASDAQ: METC) is gearing up for its upcoming quarterly earnings announcement. Investors are advised to stay tuned for key insights and takeaways from the release. This earnings season holds particular significance for the company, and there are several factors to consider ahead of the report. Analyst...

Continue Reading
Hormel Foods Celebrates New Scholarship Recipients for 2024

Updated Category News Views 200

Hormel Foods Honors 2024 Scholarship Winners Hormel Foods Corporation, a distinguished player in the global food industry, takes pride in announcing the latest class of Hormel Heroes Scholarship recipients. This initiative spotlights the achievements of two exceptional students, both with military backgrounds, who are honored with $10,000 scholarships. Empowering Futures...

Continue Reading
Orthopedic Biomaterials Market Expected to Reach $51.5 Billion

Updated Category News Views 103

Growth of the Global Orthopedic Biomaterials Market The Global Orthopedic Biomaterials Market is set to witness significant growth, with projections indicating an increase from USD 19.50 billion in 2023 to USD 51.50 billion by 2033. This remarkable growth is expected to occur at a compound annual growth rate (CAGR) of 10.20% throughout the forecast period. Understanding...

Continue Reading